2-Méthyl-2-adamantanol, min.98%, pour la synthèse, 5 g, emballage en verre

Ethyl 6-bromo-4-oxo-3,4-dihydro-2H-benzo[e][1,3]oxazine-2-carboxylate, 95.0%, 250mg

1-(4-Fluoro-phenyl)-5-methyl-1H-pyrazole-4-carboxylic acid, 95.0%, 5g

(�)-trans-4-(3-Cyanophenyl)pyrrolidine-3-carboxylic acid hydrochloride, 98.0%, 250mg

2-(4-Chlorophenyl)-4-methylphthalazin-1(2H)-one, 1g

(4aS,7R,8aS)-9,9-Dimethyltetrahydro-4H-4a,7-methanobenzo[c][1,2]oxazireno[2,3-b]isothiazole 3,3-dioxide, 95.0%, 25g

3-((Benzyloxy)methyl)-4-ethyl-1H-1,2,4-triazol-5(4H)-one, 98%, 1g

4-Methylisoindolin-1-one, 95.0%, 250mg

Safranine O (CI 50240), 1 g

2-Bromo-5-methylthiazole-4-carbonitrile, 95.0%, 250mg

N-(2-Bromothiazol-4-yl)-2,2,2-trifluoroacetamide, 95.0%, 1g

FMOC-l-Pentafluorophenylalanine, 97.0%, 25g

1H-Pyrrolo[3,2-c]pyridine-6-carbonitrile, 95.0%, 500mg